DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



A Post Marketing Surveillance Study Of Doxazosin Mesylate GITS Among Filipino Patients With Benign Prostatic Hyperplasia (BPH)

Information source: Pfizer
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Prostatic Hyperplasia

Intervention: Doxazosin mesylate GITS (Drug)

Phase: N/A

Status: Completed

Sponsored by: Pfizer

Official(s) and/or principal investigator(s):
Pfizer CT.gov Call Center, Study Director, Affiliation: Pfizer

Summary

This study aims to assess the safety, tolerability and efficacy of Doxazosin GITS in Filipino patients diagnosed with Benign Prostatic Hyperplasia (BPH) under the usual clinical care setting.

Clinical Details

Official title: A Post Marketing Surveillance Study To Determine The Safety, Tolerability And Effectiveness Of Doxazosin Mesylate GITS Among Filipino Adult Males With Benign Prostatic Hyperplasia (BPH)

Study design: Observational Model: Cohort, Time Perspective: Prospective

Primary outcome: Number of Participants With Adverse Events (AEs)

Secondary outcome:

Percent Change From Baseline in the International Prostate Symptom (IPSS) Total Score at Week 4 and Week 12

Percent Change From Baseline in the IPSS Quality of Life (QoL) Score at Week 4 and Week 12

Change From Baseline in Systolic BP at Week 4 and Week 12

Change From Baseline in Diastolic BP at Week 4 and Week 12

Percentage of Participants With Postural Hypotension

Detailed description: This is an open label study. All patients prescribed with Doxazosin GITS can be enrolled in this study.

Eligibility

Minimum age: 18 Years. Maximum age: 90 Years. Gender(s): Male.

Criteria:

Inclusion Criteria:

- Subjects that will be included must be consistent with the approved label indication

of Doxazosin mesylate GITS in the Philippines, which includes adult male diagnosed with BPH, and who are prescribed with Doxazosin mesylate GITS. Exclusion Criteria:

- Subjects with condition that are contraindicated with Doxazosin mesylate GITS based

on the approved labeling in the Philippines.

Locations and Contacts

Pfizer Investigational Site, Angeles City, Philippines

Pfizer Investigational Site, Angeles, Philippines

Pfizer Investigational Site, Bacolod City, Philippines

Pfizer Investigational Site, Baguio City, Philippines

Pfizer Investigational Site, Bohol, Philippines

Pfizer Investigational Site, Bulacan, Philippines

Pfizer Investigational Site, Butuan City, Philippines

Pfizer Investigational Site, Cagayan De Oro City, Philippines

Pfizer Investigational Site, Cebu City 6000, Philippines

Pfizer Investigational Site, Cebu City, Philippines

Pfizer Investigational Site, Cebu, Philippines

Pfizer Investigational Site, Davao City, Philippines

Pfizer Investigational Site, Davao, Philippines

Pfizer Investigational Site, Gallares City, Philippines

Pfizer Investigational Site, General Santos City, Philippines

Pfizer Investigational Site, Iligan City, Philippines

Pfizer Investigational Site, Ilocos Norte, Philippines

Pfizer Investigational Site, Kalibo Aklan, Philippines

Pfizer Investigational Site, Kalibo, Philippines

Pfizer Investigational Site, La Union, Philippines

Pfizer Investigational Site, Laguna, Philippines

Pfizer Investigational Site, Laoag City, Philippines

Pfizer Investigational Site, Lingayen, Pangasinan, Philippines

Pfizer Investigational Site, Makati City, Philippines

Pfizer Investigational Site, Malabon City, Philippines

Pfizer Investigational Site, Manadaluyong, Philippines

Pfizer Investigational Site, Mandaluyong City, Philippines

Pfizer Investigational Site, Mandaluyong, Philippines

Pfizer Investigational Site, Mandaue City, Philippines

Pfizer Investigational Site, Manila 1000, Philippines

Pfizer Investigational Site, Manila, Philippines

Pfizer Investigational Site, Marikina City, Philippines

Pfizer Investigational Site, Marikina, Philippines

Pfizer Investigational Site, Mindanao, Philippines

Pfizer Investigational Site, Muntinlupa, Philippines

Pfizer Investigational Site, Nueva Ecija, Philippines

Pfizer Investigational Site, Nueva Vizcaya, Philippines

Pfizer Investigational Site, Ozamis City, Philippines

Pfizer Investigational Site, Ozamiz City, Philippines

Pfizer Investigational Site, Pampanga, Philippines

Pfizer Investigational Site, Pasig City, Philippines

Pfizer Investigational Site, Philippines, Philippines

Pfizer Investigational Site, Quezon City 1100, Philippines

Pfizer Investigational Site, Quezon City, Philippines

Pfizer Investigational Site, Quezon City 1109, Philippines

Pfizer Investigational Site, Quezon City 1102, Philippines

Pfizer Investigational Site, Quezon, Philippines

Pfizer Investigational Site, Rizal, Philippines

Pfizer Investigational Site, San Jose City, Philippines

Pfizer Investigational Site, Surigao City, Philippines

Pfizer Investigational Site, Tacloban City, Philippines

Pfizer Investigational Site, Tacloban, Philippines

Pfizer Investigational Site, Tagbilaran City, Philippines

Pfizer Investigational Site, Tagbilaran City 6300, Philippines

Pfizer Investigational Site, Tagum City, Philippines

Pfizer Investigational Site, Tarlac City, Philippines

Pfizer Investigational Site, Tarlac City 2300, Philippines

Pfizer Investigational Site, Tarlac, Philippines

Pfizer Investigational Site, Tuguegarao City, Philippines

Pfizer Investigational Site, Valenzuela City, Philippines

Pfizer Investigational Site, Vigan, Philippines

Pfizer Investigational Site, Visayas, Philippines

Pfizer Investigational Site, West Fairview, Quezon City 1100, Philippines

Pfizer Investigational Site, Butuan City, Agusan Del Norte, Philippines

Pfizer Investigational Site, San Juan, Batangas, Philippines

Pfizer Investigational Site, Tagbilaran City, Bohol, Philippines

Pfizer Investigational Site, Quezon City, Diliman, Philippines

Pfizer Investigational Site, City of San Fernando, La Union, Philippines

Pfizer Investigational Site, Ermita, Manila 1000, Philippines

Pfizer Investigational Site, Tondo, Manila 1000, Philippines

Pfizer Investigational Site, Diliman, Quezon City, Metro Manila 1101, Philippines

Pfizer Investigational Site, Pasig City, Metro Manila 1605, Philippines

Pfizer Investigational Site, Angeles City, Pampanga, Philippines

Additional Information

To obtain contact information for a study center near you, click here.

Starting date: May 2009
Last updated: September 19, 2011

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017